1-3 of 3
Pablo M. Parker
Close
Sort by
Journal Articles

Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis.

Pablo M. Parker, MD, Ryotaro Nakamura, MD, Vinod Pullarket, MD, Joseph Rosenthal, MD, Eileen P. Smith, MD, David S. Snyder, MD, Jasmine M. Zain, MD, George Somlo, MD, Annette Brown, Hanjoo Kim, Joycelynne Palmer, PhD, Ji-Lian Cai, MD, Maria L. Delioukina, MD, Peter M. Falk, MD, Chatchada Karanes, MD, Neil M. Kogut, MD, Amrita Krishnan, MD, Auayporn P. Nademanee, MD, Margaret R. O’Donnell, MD, Leslie Popplewell, MD, Firoozeh Sahebi, MD, Ricardo Spielberger, MD, Anthony S. Stein, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2007) 110 (11): 1975.
https://doi.org/10.1182/blood.V110.11.1975.1975
Published: 2007
Journal Articles

Reduced Intensity (RI) Allogeneic Hematopoietic Cell Transplantation (HCT) Improves Outcomes for Older (≥ 60 Yrs) Patients (Pts) with Acute Myeloid Leukemia (AML).

Margaret R. O’Donnell, MD, Anthony S. Stein, MD, Ryotaro Nakamura, MD, Marilyn L. Slovak, PhD, Nicole Tsai, PhD, Joycelynne Palmer, PhD, Roberto Rodriguez, MD, Ricardo Spielberger, MD, Eileen P. Smith, MD, David S. Snyder, MD, Pablo M. Parker, MD, Leslie Popplewell, MD, Vinod Pullarkat, MD, Chatchada Karanes, MD, Neil Kogut, MD, George Somlo, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2007) 110 (11): 1089.
https://doi.org/10.1182/blood.V110.11.1089.1089
Published: 2007
Journal Articles

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

Clinical Trials & Observations
Mary E. D. Flowers, Pablo M. Parker, Laura J. Johnston, Alice V. B. Matos, Barry Storer, William I. Bensinger, Rainer Storb, Frederick R. Appelbaum, Stephen J. Forman, Karl G. Blume, Paul J. Martin
Journal: Blood
Blood (2002) 100 (2): 415–419.
https://doi.org/10.1182/blood-2002-01-0011
Published: 2002